Detalhe da pesquisa
1.
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Nature
; 584(7821): 457-462, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668444
2.
Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients.
Hepatology
; 74(1): 200-213, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33249625
3.
Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
Gastroenterology
; 156(6): 1862-1876.e9, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30711630
4.
Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3.
Gastroenterology
; 155(1): 180-193.e6, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550589
5.
Intrahepatic CD206+ macrophages contribute to inflammation in advanced viral-related liver disease.
J Hepatol
; 67(3): 490-500, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28483682
6.
Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.
PLoS Pathog
; 10(6): e1004210, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24967632
7.
Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region.
J Virol
; 88(2): 1332-41, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24227846
8.
Defining CD8+ T cell determinants during human viral infection in populations of Asian ethnicity.
J Immunol
; 191(8): 4010-9, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24058176
9.
IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells.
J Immunol
; 190(7): 3142-52, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23447689
10.
Conditional ligands for Asian HLA variants facilitate the definition of CD8+ T-cell responses in acute and chronic viral diseases.
Eur J Immunol
; 43(4): 1109-20, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23280567
11.
In silico study of potential SARS-CoV-2 antagonist from Clitoria ternatea.
Int J Health Sci (Qassim)
; 17(3): 3-10, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151745
12.
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy.
Cell Mol Immunol
; 20(11): 1300-1312, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666955
13.
Engineering T cells specific for a dominant severe acute respiratory syndrome coronavirus CD8 T cell epitope.
J Virol
; 85(20): 10464-71, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21813600
14.
A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines.
Cell Rep Med
; 3(11): 100793, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257326
15.
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines.
J Hepatol
; 55(1): 103-10, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21145860
16.
A review on advances of treatment modalities for Alzheimer's disease.
Life Sci
; 276: 119129, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33515559
17.
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.
Cell Rep
; 34(6): 108728, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516277
18.
Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals.
J Clin Invest
; 131(17)2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34623327
19.
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
J Exp Med
; 218(5)2021 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33646265
20.
Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young men.
Emerg Microbes Infect
; 10(1): 2141-2150, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34709140